Effectiveness of ADC Difference Value on Pre-neoadjuvant Chemotherapy MRI for Response Evaluation of Breast Cancer

Background: Neoadjuvant chemotherapy (NAC) is known to be a suitable treatment and first-line defense for locally advanced breast cancer. However, the NAC response may include unexpected outcomes, and it is not easy to predict the NAC response precisely. Especially, early detection of those patients...

Descripción completa

Detalles Bibliográficos
Autor principal: Choi, Bo Bae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445528/
https://www.ncbi.nlm.nih.gov/pubmed/34519583
http://dx.doi.org/10.1177/15330338211039129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8445528/
https://www.ncbi.nlm.nih.gov/pubmed/34519583
http://dx.doi.org/10.1177/15330338211039129

Ejemplares similares